{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:05:35Z","timestamp":1760709935225},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,10,15]]},"DOI":"10.2169\/internalmedicine.3012-19","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T22:03:43Z","timestamp":1561586623000},"page":"3013-3017","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis B Virus-associated Vasculitis: Multiple Cavitary Masses in the Lung Mimicking Granulomatous Polyangiitis"],"prefix":"10.2169","volume":"58","author":[{"given":"Masahiro","family":"Nemoto","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjin","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kameda Medical Center, Japan"},{"name":"Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Aoshima","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sharma A, Sharma K. Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis. J Clin Exp Hepatol 3: 204-212, 2013.","DOI":"10.1016\/j.jceh.2013.06.001"},{"key":"3","unstructured":"3. Joshi U, Subedi R, Gajurel BP. Hepatitis B virus induced cytoplasmic antineutrophil cytoplasmic antibody-mediated vasculitis causing subarachnoid hemorrhage, acute transverse myelitis, and nephropathy: a case report. J Med Case Rep 11: 91, 2017."},{"key":"4","unstructured":"4. Mazzaro C, Dal Maso L, Urraro T, et al. Hepatitis B virus related cryoglobulinemic vasculitis: a multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC. Dig Liver Dis 48: 780-784, 2016."},{"key":"5","unstructured":"5. Chen B, Yang X, Sun S, et al. Propylthiouracil-induced vasculitis with alveolar hemorrhage confirmed by clinical, laboratory, computed tomography, and bronchoscopy findings: a case report and literature review. Iran Red Crescent Med J 18: e23320, 2016."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ferreira C, Costa T, Marques AV. Diffuse alveolar haemorrhage secondary to propylthiouracil-induced vasculitis. BMJ Case Rep 2015.","DOI":"10.1136\/bcr-2014-208289"},{"key":"7","unstructured":"7. Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84: 313-322, 2005."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007.","DOI":"10.1136\/ard.2006.054593"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lightfoot RW Jr, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33: 1088-1093, 1990.","DOI":"10.1002\/art.1780330805"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33: 1101-1107, 1990.","DOI":"10.1002\/art.1780330807"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ando M, Goto A, Yamasue M, et al. Pulmonary-limited granulomatosis with polyangiitis coexisting with mixed connective tissue disease. Tohoku J Exp Med 242: 109-114, 2017.","DOI":"10.1620\/tjem.242.109"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. McLaren JS, Stimson RH, McRorie ER, Coia JE, Luqmani RA. The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting. QJM 94: 615-621, 2001.","DOI":"10.1093\/qjmed\/94.11.615"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ntatsaki E, Carruthers D, Chakravarty K, et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford) 53: 2306-2309, 2014.","DOI":"10.1093\/rheumatology\/ket445"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Calhan T, Sahin A, Kahraman R, et al. Antineutrophil cytoplasmic antibody frequency in chronic hepatitis B patients. Dis Markers 2014: 982150, 2014.","DOI":"10.1155\/2014\/982150"},{"key":"15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2249.2002.01827.x","volume":"128","author":"YY Wu","year":"2002","unstructured":"15. Wu YY, Hsu TC, Chen TY, et al. Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol 128: 347-352, 2002.","journal-title":"Clinical & Experimental Immunology","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kawakami T, Ooka S, Mizoguchi M, Soma Y, Yamazaki M. Remission of hepatitis B virus-related cryoglobulinemic vasculitis with entecavir. Ann Intern Med 149: 911-912, 2008.","DOI":"10.7326\/0003-4819-149-12-200812160-00018"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Naniwa T, Maeda T, Shimizu S, Ito R. Hepatitis B virus-related polyarteritis nodosa presenting with multiple lung nodules and cavitary lesions. Chest 138: 195-197, 2010.","DOI":"10.1378\/chest.09-2579"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Colonno RJ, Genovesi EV, Medina I, et al. Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection. J Infect Dis 184: 1236-1245, 2001.","DOI":"10.1086\/324003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Guillevin L, Mahr A, Cohen P, et al. Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 51: 482-487, 2004.","DOI":"10.1002\/art.20401"},{"key":"20","unstructured":"20. Akuta N, Suzuki F, Tsubota A, et al. Long-term clinical remission induced by corticosteroid withdrawal therapy (CSWT) in patients with chronic hepatitis B infection: a prospective randomized controlled trial-CSWT with and without follow-up interferon-alpha therapy. Dig Dis Sci 47: 405-414, 2002."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fujiwara K, Yasui S, Yonemitsu Y, et al. Efficacy of high-dose corticosteroid in the early stage of viral acute liver failure. Hepatol Res 44: 491-501, 2014.","DOI":"10.1111\/hepr.12148"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Fujiwara K, Yasui S, Haga Y, et al. Early combination therapy with corticosteroid and nucleoside analogue induces rapid resolution of inflammation in acute liver failure due to transient hepatitis B virus infection. Intern Med 57: 1543-1552, 2018.","DOI":"10.2169\/internalmedicine.9670-17"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/20\/58_3012-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T03:34:37Z","timestamp":1571456077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/20\/58_3012-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":22,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3012-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}